Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GRCL

Gracell Biotechnologies (GRCL) Stock Price, News & Analysis

Gracell Biotechnologies logo

About Gracell Biotechnologies Stock (NASDAQ:GRCL)

Advanced Chart

Key Stats

Today's Range
$10.25
$10.25
50-Day Range
$10.14
$10.35
52-Week Range
$1.40
$10.44
Volume
N/A
Average Volume
1.32 million shs
Market Capitalization
$744.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GRCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gracell Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

GRCL Stock News Headlines

GRCL Mar 2024 10.000 call(CONTR
Gracell Biotechnologies Acquisition Completed
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
Gracell Biotechnologies Acquisition Completed
Gracell Biotechnologies Inc. (GRCL)
See More Headlines

GRCL Stock Analysis - Frequently Asked Questions

Gracell Biotechnologies Inc. (NASDAQ:GRCL) posted its quarterly earnings results on Sunday, November, 14th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.18. The firm earned $0.06 million during the quarter.

Gracell Biotechnologies (GRCL) raised $150 million in an initial public offering on Friday, January 8th 2021. The company issued 8,800,000 shares at $16.00-$18.00 per share. Citigroup, Jefferies, Piper Sandler and Wells Fargo Securities served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gracell Biotechnologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Adobe (ADBE).

Company Calendar

Last Earnings
11/14/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:GRCL
CIK
1826492
Fax
N/A
Employees
314
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$88.08 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-37.40%
Return on Assets
-31.24%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
7.73
Quick Ratio
7.73

Sales & Book Value

Annual Sales
$60 thousand
Price / Sales
12,415.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.95 per share
Price / Book
3.47

Miscellaneous

Outstanding Shares
72,678,000
Free Float
52,328,000
Market Cap
$744.95 million
Optionable
Optionable
Beta
-0.33
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:GRCL) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners